Enanta Pharm (ENTA) Lost Twice as Much as Expected in Q1
Tweet Send to a Friend
Enanta Pharm (NASDAQ: ENTA) reported Q1 EPS of ($0.30), $0.15 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
